These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 27069355)

  • 1. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
    Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
    Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
    Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
    Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
    J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
    Zou Y; Guo CG; Zhang MM
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.
    Liao XF; Yi JL; Li XR; Deng W; Yang ZF; Tian G
    World J Gastroenterol; 2004 Jul; 10(13):1885-9. PubMed ID: 15222029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
    Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
    Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits.
    Zhang X; Dai F; Chen J; Xie X; Xu H; Bai C; Qiao W; Shen W
    Cancer Biol Ther; 2019; 20(5):642-652. PubMed ID: 30621501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E; Vogt A; Sauerbruch T; Schmitz V
    J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
    Kim HJ; Shin JH; Kim TH; Kim EY; Park YS; Park CS; Song HY
    J Vasc Interv Radiol; 2009 Oct; 20(10):1365-70. PubMed ID: 19713126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
    Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
    Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduction of tumorigenicity of SMMC7721 hepatoma cell line by VEGF siRNA].
    Huang J; Wang HB; Ge SF; Jia RB; Huang QS; Zheng XM
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Oct; 40(5):277-85. PubMed ID: 18254331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.
    Kornek M; Lukacs-Kornek V; Limmer A; Raskopf E; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Mol Med; 2008; 14(7-8):365-73. PubMed ID: 18392108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
    Jiang T; Zhang X; Ding J; Duan B; Lu S
    Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted magnetic resonance imaging to evaluate microvascular density after transarterial embolization ablation in a rabbit VX2 liver tumor model.
    Qian T; Chen M; Gao F; Meng F; Gao X; Yin H
    Magn Reson Imaging; 2014 Oct; 32(8):1052-7. PubMed ID: 24970024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
    Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
    J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model.
    Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.